Home » Topics » Regulatory

Regulatory
RSS

Regeneron obtains FDA approval for Eylea

Nov. 21, 2011

FDA approves Jakafi for patients with myelofibrosis

Nov. 18, 2011

European Commission approves Pfizer's Vyndaqel for TTR-FAP

Nov. 18, 2011

Kyowa Hakko Kirin launches new formulation of second-generation antihistamine in Japan

Nov. 15, 2011

FDA approves Erbitux for new indication

Nov. 9, 2011

EC grants marketing authorization to orphan drug for adrenal insufficiency in adults

Nov. 9, 2011

Actilyse approved in 15 European countries to treat acute ischemic stroke

Nov. 8, 2011

FDA approves Bayer's Xarelto for new indication

Nov. 7, 2011

FDA approves Pacira Pharmaceuticals' Exparel

Nov. 2, 2011

European Commission extends Alimta approval

Oct. 28, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for August 5, 2025.
Two cancer drugs combined modify Alzheimer’s disease in mice
BioWorld
Current treatments for Alzheimer’s disease have limited effects. While they can slow cognitive decline or alleviate symptoms, they do not reverse this complex...
In Broadway trial, a hopeful tune for Alzheimer’s prevention
BioWorld
At the 2025 Alzheimer’s Association International Conference (AAIC), one of the bigger splashes was made by a cardiovascular drug. In a presentation on July 30,...
Lepu out-licenses T-cell engagers to newco Excalipoint for $857M
BioWorld
Lepu Biopharma Co. Ltd. has out-licensed two preclinical T-cell engagers to Shanghai-based newco Excalipoint in a deal worth $857.5 million plus equity interest....